Enliven Therapeutics
ELVN
ELVN
32 hedge funds and large institutions have $228M invested in Enliven Therapeutics in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 16
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$16.7M | |
| 2 | +$1.9M | |
| 3 | +$157K | |
| 4 |
SG Americas Securities
New York
|
+$134K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$102K |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$314K | |
| 3 | -$306K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$220K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$154K |